Skip to main content

Marijuana Use Poses Significant Heart Failure Risk

As of my last knowledge update in January 2022, there was some evidence suggesting a potential link between marijuana use and an increased risk of heart-related issues, including a possible association with heart failure. However, it's important to note that research in this area is ongoing, and the findings can vary. The cardiovascular effects of marijuana use are complex and can depend on various factors, including the frequency and amount of use, individual health conditions, and the method of consumption. Some studies have suggested that marijuana use may lead to an increased heart rate, blood pressure, and the potential for cardiovascular events. It's crucial to keep in mind that new research may have emerged since my last update. If you are seeking the most current information on this topic, I recommend checking reputable medical sources, such as scientific journals or health organizations, for the latest research findings and expert opinions. Additionally, consulting with a healthcare professional can provide personalized advice based on your specific health situation.
The Risk of Cannabis Use Disorder One concerning aspect of marijuana use is the development of cannabis use disorder, with nearly three in ten marijuana users developing dependence. Cannabis use disorder involves cravings, mood and sleep disturbances, irritability, and lack of appetite when attempting to quit. It becomes an addiction when users cannot quit despite the negative impacts on their lives. The Impact Of Chronic Conditions Older adults often develop various chronic conditions, such as high blood pressure, type 2 diabetes, or high cholesterol, which appear to worsen the effects of marijuana use. The studies examined hospital records of adults over 65 with cannabis use disorder who did not smoke tobacco. They discovered a 20% increased risk of major heart or brain events during hospitalization among the 8,535 cannabis abusers compared to over 10 million non-users. High blood pressure readings (over 130/80 mm Hg) and high cholesterol were found to be key predictors of adverse events in marijuana users. Acute And Chronic Use Impact on Blood Pressure Acute marijuana use can lead to a drop in blood pressure, particularly when inhaled. However, long-term daily use has been associated with increased blood pressure, which is a risk factor for various cardiovascular conditions. This difference suggests that both acute and chronic marijuana use can have adverse effects on cardiovascular health. Increased Risk Of Heart Failure A separate study followed nearly 160,000 adults with a median age of 54 for approximately four years to assess the impact of marijuana use on the development of heart failure. The study found that those who reported daily marijuana use had a 34% increased risk of developing heart failure compared to non-users. The risk remained consistent regardless of age, sex at birth, or smoking history. The researchers could not determine whether the marijuana was smoked or consumed orally.
Labels:

Comments

Post a Comment

Popular posts from this blog

Ignoring influenza and flu in winter can be Dangerous

Ignoring influenza (the flu) and flu-like symptoms during the winter can indeed be dangerous. Influenza is a viral infection that primarily spreads through respiratory droplets when an infected person coughs or sneezes. It tends to be more prevalent during the colder months, which is why it's often associated with winter. Here are some reasons why ignoring the flu in winter can be dangerous: Complications: The flu can lead to serious complications, especially in vulnerable populations such as young children, the elderly, pregnant women, and individuals with weakened immune systems. Complications can include pneumonia, bronchitis, sinus infections, and ear infections. Spread of the Virus: Influenza is highly contagious, and neglecting symptoms can contribute to the spread of the virus to others. This is particularly concerning in crowded places like schools, offices, and public transportation. Weakened Immune System: The winter season itself can weaken the immune system, making ...
Post a Comment
Read more

What Is a Secondary Headache?

A secondary headache is a type of headache that is a symptom of another underlying medical condition or disease. Unlike primary headaches, which are not associated with any underlying cause, secondary headaches are a result of an identifiable and usually serious underlying problem. There are numerous potential causes of secondary headaches, including: Head Injury: Traumatic head injuries can lead to headaches as a symptom. Sinusitis: Inflammation of the sinuses can cause pain and pressure in the head. Migraines: While migraines can be primary headaches, they can also be secondary if they are triggered by an underlying condition. Medication Overuse: Excessive use of pain medications, especially those containing caffeine or codeine, can lead to rebound headaches. Infection: Various infections, such as meningitis, encephalitis, or a sinus infection, can cause secondary headaches. High Blood Pressure: Hypertension (high blood pressure) can lead to headaches, especially if it is seve...
Post a Comment
Read more

FDA Approves Pfizer’s Vaccine for Meningococcal Disease

The U.S. Food and Drug Administration has approved Pfizer’s application for Penbraya, a vaccine for people 10 through 25 that will offer protection against the five main kinds of bacteria that cause meningitis and blood poisoning. The new drug will reduce the number of doses that people need to be fully vaccinated, Pfizer said in a news release. Penbraya will be given as a two-dose series administered six months apart, Pfizer said. Medical authorities currently recommend Trumenba for meningococcal group B and Nimenrix for meningococcal groups A, C, W-135, and Y, meaning people need four doses for full protection. “In a single vaccine, PENBRAYA has the potential to protect more adolescents and young adults from this severe and unpredictable disease by providing the broadest meningococcal coverage in the fewest shots,” Annaliesa Anderson, PhD, senior vice president and head of vaccine research and development for Pfizer, said in the release. Penbraya combines Trumenba, which is mad...
Post a Comment
Read more